Updates on Current Treatment Options for RA-ILD
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
This activity is hosted on https://www.hema-isth.org/. By clicking Begin Activity, you will be leaving The France Foundation website.
Webinar | CME (AMA PRA Category 1 Credit) | 0.50 - 30 mins | Genetic Counselor | Hematology | Genomic Medicine |
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA